ANITA BARNES: Open Payments
NPI 1386642940 · CENTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 9 payments from 6 companies in 2025. Trend: 2023 $15 · 2024 $81 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $60 |
| PFIZER INC. | 2 | $32 |
| Exact Sciences Corporation | 2 | $32 |
| Seqirus USA Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: REXULTI, TRUMENBA, The Cologuard Plus Collection Kit, Flucelvax, BREZTRI, CAPLYTA.
Industry payments across TX — which companies pay providers there.
